# Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)

> **NCT03548051** · PHASE1,PHASE2 · TERMINATED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (actual)

## Conditions studied

- Clostridial Infection
- Dysbiosis
- Probiotic Therapy

## Interventions

- **PROCEDURE:** Fecal Microbiota Transplantation (FMT)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03548051
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-01-11
- **Primary completion:** 2021-01-13
- **Final completion:** 2021-01-13
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2022-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03548051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03548051, "Safety and Efficacy of FMT in Individuals With One or More Recurrences of Clostridium Difficile Associated Disease (CDAD)". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03548051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*